Stop TB Partnership’s Concrete Support in the Fight to Tackle AMR

30 November 2017 - Geneva, Switzerland - The Wellcome Trust has released the "Call to Action on Antimicrobial Resistance" post-event report, which can be found at

At the event, which was held from 12-13 October in Berlin, Germany, Executive Director of the Stop TB Partnership, Dr Lucica Ditiu, who was one of the keynote speakers, pledged our support to the overall fight on AMR, especially given that deaths through drug resistant TB represent 30% of overall deaths due to AMR. As a first and initial commitment to this fight, the organization will develop and launch a web-based global AMR database. With seed funding from USAID, the database will be a common good resource and unveiled in early 2018.

Currently, the AMR database has captured information on over 130 initiatives according to the following categories: disease area (e.g., AMR, specific disease areas such as TB, HIV, malaria); focus area (e.g., advocacy, financing, policy, product development, stewardship, surveillance); product category (e.g., vaccines, diagnostics, drugs, digital health solutions); geographic focus (e.g., low, middle, high); and one health approach (e.g., environment, animal, human).

From the initial analysis of the database, it is interesting to note that the preliminary findings show that funding for the AMR initiatives predominantly come from the EU, UK and US, in addition to:

Stop TB Partnership welcomes all stakeholders engaged in the AMR space to collaborate with us on the further development and launch of the web-based database. For more information, please contact Ms Jackie Huh, Team Leader, Strategic Initiatives & Innovative Financing, at